Recall Register

Food, drugs, devices › R & D Systems, Inc.

Device recall: R&D systems, a bio-techne brand Human Total 25-OH Vitamin D IVD ELISA Kit, REF RDKAP1971

FDA enforcement event 81121 · Class III · initiated 11 Sep 2018 · status Terminated · terminated 1 Sep 2020

DeviceVoluntary: Firm initiated1 product recordMinneapolis, MN

R & D Systems, Inc. (Minneapolis, MN) initiated this device recall on 11 Sep 2018; FDA lists 1 product record under event 81121, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 4% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 1 Sep 2020. Initiation: voluntary: firm initiated. R & D Systems, Inc. has 6 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

R & D Systems, Inc., Minneapolis, MN.

Reason for recall

"The kit was provided without a copy of the lot-specific kit booklet and the Calibrator 0 vial 18D1/4 label incorrectly specified reconstitution volume of 2mL."

Distribution

"IA and CO"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0410-2019R&D systems, a bio-techne brand Human Total 25-OH Vitamin D IVD ELISA Kit, REF RDKAP19718 kitsClass IIITerminated14 Nov 2018

Context

4%of 2018 device events are Class III1,074 events that year
1product record in this eventfirm median: 1
6events on this register for the firm

Other enforcement events for R & D Systems, Inc.

InitiatedProduct (first record)TypeClassRecords
7 Nov 2022R&D CBC-3D Hematology Control: (1) CBC-3D Normal Pack Hematology Control, REF 3D501, containing 10 x 2.0mL Control N; (2DeviceClass III1
14 Jun 2022Quantikine IVD Erythropoietin Human Serum Controls for use as quantitative controls for the determination of ErythropoieDeviceClass III1
20 Jan 2021Quantikine IVD Human sTfR Immunoassay (Human sTransferrin ELISA Kit (sTfR immunological test system)). An enzyme linked DeviceClass II1
1 Nov 2018Quantikine¿ IVD¿ ELISA, Human sTfR Immunoassay kit. Product Usage: The QuantikineTM IVDTM sTFR Enzyme linked immunosorbeDeviceClass III1
24 Aug 2016R&D Systems, Quantikine¿ IVD¿sTfR Immunoassay Kit, for the quantitative determination of soluble transferrin receptor (sDeviceClass II1

All 6 events for R & D Systems, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The kit was provided without a copy of the lot-specific kit booklet and the Calibrator 0 vial 18D1/4 label incorrectly specified reconstitution volume of 2mL."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "IA and CO"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 1 Sep 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.